Obermatt

Elekta

STO:EKTA B · SE0000163628
Health Care Equipment & SuppliesMedium

360

42
EV / EBIT73
Price / Owner Earnings93
Owner Earnings Yield1
Dividend Yield95
Price/Sales69
EV / Gross Profit53
Price/Book37
Return on Capital53
Cash Return on Capital39
Return on Equity35
EBIT Margin39
Gross Profitability16
Accruals76
Owner Earnings Margin39
Sales growth32
Profit Growth80
Long-Term EPS Growth67
Owner Earnings Growth10
Reinvestment51
Price momentum72
Debt load24
Refinancing21
Debt Payback1
Liquidity25
Analyst ratings7
Opinion Changes50
Price Target Upside26
Market mood57
Value Creation6/20not creating value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Elekta doesn't consistently earn more than its cost of capital, so it isn't yet creating shareholder value.

Profile

CountrySweden
IndustryHealth Care Equipment & Supplies
SizeMedium
TypePublic Company
ExchangeOM
Founded1972
Employees3,395
Websiteelekta.com
ISINSE0000163628
Last UpdateApr 2, 2026
Index & Theme
Health DiagnosticsNeurologyBiomedical EngineeringCentral Nervous SystemNeuroscienceOncologyBiotechnology

Description

Elekta AB (publ) operates as an international medical technology company, provides clinical solutions to improve cancer care and neuro healthcare. Business Segments The company operates through business segments: radiation therapy devices, brachyth…

Analysis

Middle-of-the-road

Elekta AB (publ) sits in the middle of our grid: average quality, average price, no obvious signal in either direction.

Valuation data is not available for this company.

Growth is moderate; the safety picture is stretched. The company scores 6/20 on our value-creation score: not creating value.

No flags apply to this company at this time: accounts, balance sheet, and cash quality all pass. A clean bill of health is meaningful, not just the absence of a warning. This analysis describes numbers; it is not investment advice.

360° rank · history

1007550250
51
2023202420252026

All-time high

75

Jan 2024

All-time low

16

Mar 2026

Average rank

44

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
69
77
72
75
Price/Earnings
65
79
74
68
Price/Book
37
73
51
50
Dividend Yield
95
100
92
92
Value (overall)
82
96
87
83

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Elekta with its peers
Alfa Financial Softwares
LSE:ALFA
72
CountryUK
IndustrySoftware
SizeSmall
Full Stock Analysis →
Wix.com
NSQ:WIX
35
CountryIsrael
IndustryIT Services
SizeMedium
Full Stock Analysis →
KPS
GER:KSC
17
CountryGermany
IndustryIT Services
SizeSmall
Full Stock Analysis →
Galapagos
AEX:GLPG
76
CountryBelgium
IndustryBiotechnology
SizeMedium
Full Stock Analysis →
SOPHiA GENETICS
NSQ:SOPH
52
CountrySwitzerland
IndustryHealth Care Technology
SizeSmall
Full Stock Analysis →
Coheris
PAR:COH
45
CountryFrance
IndustrySoftware
SizeSmall
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →